Arizona 2025 2025 Regular Session

Arizona Senate Bill SB1054 Comm Sub / Analysis

Filed 01/27/2025

                    Assigned to HHS 	FOR COMMITTEE 
 
 
 
 
ARIZONA STATE SENATE 
Fifty-Seventh Legislature, First Regular Session 
 
FACT SHEET FOR S.B. 1054 
 
assisted living; hyperbaric oxygen therapy 
Purpose 
Allows assisted living homes and assisted living centers to provide hyperbaric oxygen 
therapy (HBOT) to residents. 
Background 
HBOT is a medical treatment in which an individual is placed in a hyperbaric chamber to 
breathe 100 percent pure oxygen. In the chamber, the air pressure is raised to a level higher than 
normal air pressure, which helps the lungs collect more oxygen to heal tissue and fight certain 
infections. The U.S. Food and Drug Administration (FDA) currently recognizes HBOT as an 
approved treatment for the following medical conditions: 1) air and gas bubbles in blood vessels; 2) 
severe anemia; 3) severe and large burns; 4) carbon monoxide poisoning; 5) crush injury; 6) 
decompression sickness; 7) gas gangrene; 8) sudden and complete hearing loss; 9) infection of the 
skin and bone; 10) radiation injury; 11) severe skin grafts 12) sudden and painless vision loss; and 
13) non-healing wounds (FDA)  
Assisted living facilities are residential care institutions, including adult foster care homes, 
that provide or contract to provide supervisory care services, personal care services or directed 
care services on a continuous basis. Assisted living facilities that provide resident rooms or 
residential units to eleven or more residents are known as assisted living centers, while those 
facilities that provide resident rooms or residential units to ten or fewer residents are known as 
assisted living homes (A.R.S. ยง 36-401). 
There is no anticipated fiscal impact to the state General Fund associated with this 
legislation. 
Provisions 
1. Allows assisted living homes and assisted living centers to provide HBOT to residents. 
2. Becomes effective on the general effective date. 
Prepared by Senate Research 
January 23, 2025 
MM/AO/slp